Ou D, Chong P, McVeish P, Jefferies W A, Gillam S
Department of Pathology, University of British Columbia, Vancouver, Canada.
Virology. 1992 Dec;191(2):680-6. doi: 10.1016/0042-6822(92)90243-i.
Using 11 overlapping synthetic peptides covering more than 95% of the amino acid sequence of capsid protein of rubella virus, 7 CD4+ T cell clones (R10, R11, R18, A2, A10, A11, and A12) isolated from 2 rubella seropositive donors reacted strongly to rubella capsid peptides C6 (residues 119-152), C9 (residues 205-233), or C11 (residues 255-280), respectively, in both proliferation and cytotoxicity assay. Truncated peptides C6E (residues 125-139), C9B (residues 205-216), and C11E (residues 260-272) were shown to be involved directly to the T cell determinants of C6, C9, and C11, respectively. Genetic restriction of these T cell clones was analyzed by using human cell lines with various HLA-DR phenotypes as targets and/or antigen-presenting cells in cytotoxicity assay and/or proliferation assays. The results indicated that the recognition of peptide C6 by T cell clones (R11 and R18) was associated with DRw9 molecule, while the HLA restriction element of the responses of other T cell clones (A2 and A11, A10, and A12) that reacted with peptide C9 or C11 was DR4 molecule. However, there may be a cross-recognition by the T cell clone (A12) between DR1 and DR4 subtypes.
利用覆盖风疹病毒衣壳蛋白95%以上氨基酸序列的11个重叠合成肽,从2名风疹血清阳性供体中分离出的7个CD4 + T细胞克隆(R10、R11、R18、A2、A10、A11和A12)在增殖和细胞毒性试验中分别对风疹衣壳肽C6(第119 - 152位氨基酸残基)、C9(第205 - 233位氨基酸残基)或C11(第255 - 280位氨基酸残基)有强烈反应。截短肽C6E(第125 - 139位氨基酸残基)、C9B(第205 - 216位氨基酸残基)和C11E(第260 - 272位氨基酸残基)分别被证明直接参与C6、C9和C11的T细胞决定簇。在细胞毒性试验和/或增殖试验中,以具有各种HLA - DR表型的人细胞系作为靶细胞和/或抗原呈递细胞,分析了这些T细胞克隆的遗传限制性。结果表明,T细胞克隆(R11和R18)对肽C6的识别与DRw9分子相关,而与肽C9或C11反应的其他T细胞克隆(A2和A11、A10和A12)反应的HLA限制性元件是DR4分子。然而,T细胞克隆(A12)可能在DR1和DR4亚型之间存在交叉识别。